Literature DB >> 15890234

Mouse skin tumor promotion by sodium arsenate is associated with enhanced PCNA expression.

L Motiwale1, A D Ingle, K V K Rao.   

Abstract

Drinking water contamination by arsenicals remains a major public health problem in many parts of the world more particularly in India and Bangladesh. Despite arsenic being a health hazard and implicated in human carcinogenesis, the experimental evidence available is much limited even now and the mechanisms involved during carcinogenesis and tumor promotions are not clear. Accordingly, in this study, we have studied the tumor promoter effects of sodium arsenate on mouse skin tumor promoter model system using 9,10-dimethyl-1,2-benzanthracene (DMBA) as a initiating carcinogen. Our studies showed development of papillomas on mice skin treated with only DMBA. However, mice treated with DMBA on skin and administered arsenate (As) in drinking water showed development of well differentiated squamous cell carcinomas. Further, both by immunohistochemistry and western blotting analysis studies higher levels of proliferating cell nuclear antigen (PCNA) was observed in mice treated with DMBA plus arsenate compared to only DMBA treated group. PCNA is known to be associated with S phase and DNA replication of the cell cycle. The plain controls and arsenate controls did not show significant difference either in tumor development or in PCNA levels. The present study demonstrates mouse skin tumor promoting effect of arsenate which seems to be associated with abnormal cell proliferation as indicated by higher levels of PCNA expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15890234     DOI: 10.1016/j.canlet.2004.10.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation.

Authors:  Ana P Ferragut Cardoso; Laila Al-Eryani; J Christopher States
Journal:  Toxicol Sci       Date:  2018-10-01       Impact factor: 4.849

Review 2.  Cancer in experimental animals exposed to arsenic and arsenic compounds.

Authors:  Erik J Tokar; Lamia Benbrahim-Tallaa; Jerrold M Ward; Ruth Lunn; Reeder L Sams; Michael P Waalkes
Journal:  Crit Rev Toxicol       Date:  2010-11       Impact factor: 5.635

3.  9-phenyl acridine exhibits antitumour activity by inducing apoptosis in A375 cells.

Authors:  Rita Ghosh; Sudipta Bhowmik; Dipanjan Guha
Journal:  Mol Cell Biochem       Date:  2011-10-01       Impact factor: 3.396

4.  Transplacental arsenic carcinogenesis in mice.

Authors:  Michael P Waalkes; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-12       Impact factor: 4.219

5.  Further evidence against a direct genotoxic mode of action for arsenic-induced cancer.

Authors:  Catherine B Klein; Joanna Leszczynska; Christina Hickey; Toby G Rossman
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-08       Impact factor: 4.219

6.  Inorganic arsenic inhibits the nucleotide excision repair pathway and reduces the expression of XPC.

Authors:  Nathaniel Holcomb; Mamta Goswami; Sung Gu Han; Tim Scott; John D'Orazio; David K Orren; C Gary Gairola; Isabel Mellon
Journal:  DNA Repair (Amst)       Date:  2017-02-16

7.  Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice.

Authors:  Gene J Ahlborn; Gail M Nelson; Rachel D Grindstaff; Michael P Waalkes; Bhalchandra A Diwan; James W Allen; Kirk T Kitchin; R Julian Preston; Araceli Hernandez-Zavala; Blakely Adair; David J Thomas; Don A Delker
Journal:  Toxicology       Date:  2009-05-18       Impact factor: 4.221

8.  Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic.

Authors:  Gail M Nelson; Gene J Ahlborn; James W Allen; Hongzu Ren; J Christopher Corton; Michael P Waalkes; Kirk T Kitchin; Bhalchandra A Diwan; Geremy Knapp; Don A Delker
Journal:  Toxicology       Date:  2009-10-12       Impact factor: 4.221

9.  Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors.

Authors:  Jun Shen; Roberto J Barrios; Anil K Jaiswal
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

10.  Modulation of Signal Proteins: A Plausible Mechanism to Explain How a Potentized Drug Secale Cor 30C Diluted beyond Avogadro's Limit Combats Skin Papilloma in Mice.

Authors:  Anisur Rahman Khuda-Bukhsh; Soumya Sundar Bhattacharyya; Saili Paul; Suman Dutta; Naoual Boujedaini; Philippe Belon
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.